Hypercalcemia
30
4
5
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
6.7%
2 terminated out of 30 trials
88.9%
+2.4% vs benchmark
23%
7 trials in Phase 3/4
63%
10 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (30)
Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
Hypercalcemia After Paraffin Oil Injection
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital
Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
Registry for Hypoparathyroidism Wuerzburg
Studies of Elevated Parathyroid Activity
Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland
Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes
Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel
Insulin Resistance in Primary Hyperparathyroidism
Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Cinacalcet to Treat Familial Primary Hyperparathyroidism